3/8
01:31 am
tvrd
Low
Report
2/23
07:41 am
tvrd
Foghorn Therapeutics appoints Ryan Maynard as CFO [Seeking Alpha]
Medium
Report
Foghorn Therapeutics appoints Ryan Maynard as CFO [Seeking Alpha]
2/12
08:29 am
tvrd
Tvardi Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Tvardi Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/12
08:00 am
tvrd
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
2/5
06:10 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at Lucid Cap Mkts from a "hold" rating to a "strong-buy" rating.
Medium
Report
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at Lucid Cap Mkts from a "hold" rating to a "strong-buy" rating.
1/8
07:05 pm
tvrd
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights [Yahoo! Finance]
Medium
Report
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights [Yahoo! Finance]
1/8
04:56 pm
tvrd
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/8
04:05 pm
tvrd
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/8
08:00 am
tvrd
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
High
Report
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
1/6
01:33 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at
Wall Stree
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at
Wall Stree
12/29
01:07 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was downgraded by analysts at
Wall Str
Medium
Report
Tvardi Therapeutics (NASDAQ:TVRD) was downgraded by analysts at
Wall Str